Schrodinger Price to Book Ratio 2019-2025 | SDGR
Historical price to book ratio values for Schrodinger (SDGR) over the last 10 years. The current price to book ratio for Schrodinger as of February 06, 2026 is 3.09.
| Schrodinger Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-02-06 | 13.49 | 3.09 | |
| 2025-09-30 | 20.06 | $4.36 | 4.60 |
| 2025-06-30 | 20.12 | $4.66 | 4.32 |
| 2025-03-31 | 19.74 | $5.09 | 3.88 |
| 2024-12-31 | 19.29 | $5.78 | 3.34 |
| 2024-09-30 | 18.55 | $6.17 | 3.01 |
| 2024-06-30 | 19.34 | $6.51 | 2.97 |
| 2024-03-31 | 27.00 | $7.07 | 3.82 |
| 2023-12-31 | 35.80 | $7.60 | 4.71 |
| 2023-09-30 | 28.27 | $7.83 | 3.61 |
| 2023-06-30 | 49.92 | $8.51 | 5.87 |
| 2023-03-31 | 26.33 | $8.25 | 3.19 |
| 2022-12-31 | 18.69 | $6.28 | 2.98 |
| 2022-09-30 | 24.98 | $6.50 | 3.84 |
| 2022-06-30 | 26.41 | $6.93 | 3.81 |
| 2022-03-31 | 34.12 | $7.46 | 4.57 |
| 2021-12-31 | 34.83 | $7.85 | 4.44 |
| 2021-09-30 | 54.68 | $8.18 | 6.68 |
| 2021-06-30 | 75.61 | $8.57 | 8.83 |
| 2021-03-31 | 76.29 | $8.97 | 8.51 |
| 2020-12-31 | 79.18 | $8.93 | 8.87 |
| 2020-09-30 | 47.51 | $9.08 | 5.23 |
| 2020-06-30 | 91.57 | $4.68 | 19.57 |
| 2020-03-31 | 43.12 | $5.90 | 7.31 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.994B | $0.208B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $30.189B | 34.91 |
| Tempus AI (TEM) | United States | $9.769B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $5.240B | 42.63 |
| Doximity (DOCS) | United States | $5.221B | 22.18 |
| IRhythm Holdings (IRTC) | United States | $4.719B | 0.00 |
| Privia Health (PRVA) | United States | $2.705B | 169.15 |
| Hinge Health (HNGE) | United States | $2.454B | 0.00 |
| Heartflow (HTFL) | United States | $2.362B | 0.00 |
| 10x Genomics (TXG) | United States | $2.355B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.909B | 31.59 |
| Omnicell (OMCL) | United States | $1.664B | 46.34 |
| Azenta (AZTA) | United States | $1.321B | 53.19 |
| Enovis (ENOV) | United States | $1.292B | 6.78 |
| Clover Health Investments (CLOV) | United States | $1.101B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.854B | 0.00 |
| Phreesia (PHR) | United States | $0.736B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.725B | 0.00 |
| Talkspace (TALK) | United States | $0.643B | 129.33 |
| Standard BioTools (LAB) | United States | $0.485B | 0.00 |
| Claritev (CTEV) | United States | $0.428B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.324B | 0.00 |
| Evolent Health (EVH) | United States | $0.318B | 0.00 |
| Carlsmed (CARL) | United States | $0.310B | 0.00 |
| TruBridge (TBRG) | United States | $0.304B | 13.97 |
| Senseonics Holdings (SENS) | United States | $0.304B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.256B | 0.00 |
| CapsoVision (CV) | United States | $0.232B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.228B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.210B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.167B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.158B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.152B | 0.00 |
| CareCloud (CCLD) | United States | $0.104B | 5.70 |
| Outset Medical (OM) | United States | $0.082B | 0.00 |
| American Well (AMWL) | United States | $0.073B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.065B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| Pulmonx (LUNG) | United States | $0.062B | 0.00 |
| HeartBeam (BEAT) | United States | $0.049B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.042B | 0.00 |
| Precipio (PRPO) | United States | $0.035B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.016B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.015B | 0.00 |
| Movano (MOVE) | United States | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.007B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.006B | 0.00 |
| PROFUSA (PFSA) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |